Systematic assessment and meta-analysis of the efficacy and safety of fasudil in the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage

Preventing Vasospasm Improves Outcome After Aneurysmal Subarachnoid Hemorrhage: Rationale and Design of CONSCIOUS-2 and CONSCIOUS-3 Trials

(2010) R. Loch Macdonald et al.   Neurocritical Care

Amelioration of endothelial damage/dysfunction is a possible mechanism for the neuroprotective effects of Rho-kinase inhibitors against ischemic brain damage

(2009) Shin-ichi Satoh et al.   BRAIN RESEARCH BULLETIN

Which H is the most important in triple-H therapy for cerebral vasospasm?

(2009) Miriam M Treggiari et al.   Current Opinion in Critical Care

Pharmacological Characterization of SAR407899, a Novel Rho-Kinase Inhibitor

(2009) Matthias Löhn et al.   HYPERTENSION

Nitric Oxide Does Not Downregulate Rho-Kinase (ROCK-2) Expression in Rat Coronary Endothelial Cells

(2009) R Nalan Tiftik et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Involvement of Rho-kinase in tumor necrosis factor-α-induced interleukin-6 release from C6 glioma cells

(2009) Shinobu Yamaguchi et al.   NEUROCHEMISTRY INTERNATIONAL

Do Endothelin-Receptor Antagonists Prevent Delayed Neurological Deficits and Poor Outcomes After Aneurysmal Subarachnoid Hemorrhage?

(2009) Andreas Kramer et al.   STROKE

Metaanalysis of Tirilazad Mesylate in Patients with Aneurysmal Subarachnoid Hemorrhage

(2008) Yeon Gyoe Jang et al.   Neurocritical Care

Effect of Prophylactic Transluminal Balloon Angioplasty on Cerebral Vasospasm and Outcome in Patients With Fisher Grade III Subarachnoid Hemorrhage

(2008) Marike Zwienenberg-Lee et al.   STROKE